APA (7th ed.) Citation

MK, H., WG, B., J, J., S, N., U, P., A, C., . . . G, H. (2021). Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cell Therapy Recipient: A Case Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 73(3), e815. https://doi.org/10.1093/cid/ciab072

Chicago Style (17th ed.) Citation

MK, Hensley, et al. "Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cell Therapy Recipient: A Case Study." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 73, no. 3 (2021): e815. https://doi.org/10.1093/cid/ciab072.

MLA (9th ed.) Citation

MK, Hensley, et al. "Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cell Therapy Recipient: A Case Study." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 73, no. 3, 2021, p. e815, https://doi.org/10.1093/cid/ciab072.